Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Winton

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of Clinical Pharmacology|October 12, 2021
Effects of Renal Impairment on the Pharmacokinetics of Abrocitinib and Its MetabolitesEllen Q Wang, Vu Le, Jennifer A Winton, et al.
Journal of Clinical Pharmacology|October 15, 2023
Effect of Renal Impairment on the Pharmacokinetics of a Single Oral Dose of Danuglipron in Participants With Type 2 DiabetesDaryl J Fediuk, Donal N Gorman, Stephanie-An Stoddard, et al.
British Journal of Clinical Pharmacology|August 18, 2025
Effect of vepdegestrant, a PROTAC oestrogen receptor degrader, on dabigatran and rosuvastatin pharmacokinetics in healthy participantsDerek Z Yang, Li Zhou, Jennifer A Winton, et al.
European Journal of Drug Metabolism and Pharmacokinetics|March 30, 2024
Assessment of the Effects of Abrocitinib on the Pharmacokinetics of Probe Substrates of Cytochrome P450 1A2, 2B6 and 2C19 Enzymes and Hormonal Oral Contraceptives in Healthy IndividualsXiaoxing Wang, Martin E Dowty, Sakambari Tripathy, et al.
European Journal of Drug Metabolism and Pharmacokinetics|February 28, 2022
Assessment of the Effects of Inhibition or Induction of CYP2C19 and CYP2C9 Enzymes, or Inhibition of OAT3, on the Pharmacokinetics of Abrocitinib and Its Metabolites in Healthy IndividualsXiaoxing Wang, Martin E Dowty, Ann Wouters, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Clinical Pharmacology|October 12, 2021
Effects of Renal Impairment on the Pharmacokinetics of Abrocitinib and Its MetabolitesEllen Q Wang, Vu Le, Jennifer A Winton, et al.
Journal of Clinical Pharmacology|October 15, 2023
Effect of Renal Impairment on the Pharmacokinetics of a Single Oral Dose of Danuglipron in Participants With Type 2 DiabetesDaryl J Fediuk, Donal N Gorman, Stephanie-An Stoddard, et al.
British Journal of Clinical Pharmacology|August 18, 2025
Effect of vepdegestrant, a PROTAC oestrogen receptor degrader, on dabigatran and rosuvastatin pharmacokinetics in healthy participantsDerek Z Yang, Li Zhou, Jennifer A Winton, et al.
European Journal of Drug Metabolism and Pharmacokinetics|March 30, 2024
Assessment of the Effects of Abrocitinib on the Pharmacokinetics of Probe Substrates of Cytochrome P450 1A2, 2B6 and 2C19 Enzymes and Hormonal Oral Contraceptives in Healthy IndividualsXiaoxing Wang, Martin E Dowty, Sakambari Tripathy, et al.
European Journal of Drug Metabolism and Pharmacokinetics|February 28, 2022
Assessment of the Effects of Inhibition or Induction of CYP2C19 and CYP2C9 Enzymes, or Inhibition of OAT3, on the Pharmacokinetics of Abrocitinib and Its Metabolites in Healthy IndividualsXiaoxing Wang, Martin E Dowty, Ann Wouters, et al.
Pageof 2